U.S. Markets close in 2 hrs 52 mins

TrovaGene, Inc. (TROV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6816-0.0014 (-0.2050%)
As of 1:04PM EDT. Market open.
People also watch
BIOCIDRAVSTMCTRVSRNE
Full screen
Previous Close0.6830
Open0.6810
Bid0.6802 x 500
Ask0.6900 x 13100
Day's Range0.6600 - 0.6900
52 Week Range0.6100 - 4.7500
Volume132,016
Avg. Volume598,204
Market Cap25.42M
Beta-0.31
PE Ratio (TTM)-0.54
EPS (TTM)-1.25
Earnings DateNov 7, 2017 - Nov 13, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.00
Trade prices are not sourced from all markets
  • Trovagene Strengthens Board of Directors with Appointment of Oncology Development Veteran Dr. Athena Countouriotis
    PR Newswire6 days ago

    Trovagene Strengthens Board of Directors with Appointment of Oncology Development Veteran Dr. Athena Countouriotis

    SAN DIEGO, Sept. 20, 2017 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced the expansion and strengthening of its Board of Directors with the appointment of Athena Countouriotis, M.D. Dr. Countouriotis brings significant experience leading clinical development programs, from preclinical through clinical stages, and approval.  Over the course of her career, she has been involved in multiple clinical programs, with a focus within oncology, both hematologic and solid tumor indications, that have supported regulatory approvals in the U.S. and Europe.  Dr. Countouriotis currently serves as Senior Vice President, Chief Medical Officer at Adverum Biotechnologies.

  • What Does TrovaGene Inc’s (TROV) Share Price Indicate?
    Simply Wall St.7 days ago

    What Does TrovaGene Inc’s (TROV) Share Price Indicate?

    TrovaGene Inc (NASDAQ:TROV), a pharmaceuticals, biotechnology and life sciences company based in United States, received a lot of attention from a substantial price movement on the NasdaqCM in the overRead More...

  • Capital Cube26 days ago

    ETFs with exposure to TrovaGene, Inc. : September 1, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to TrovaGene, Inc. Here are 5 ETFs with the largest exposure to TROV-US. Comparing the performance and risk of TrovaGene, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)